Issue 6/2020 - Petrochemical giants at a glance

Evonik's sales in 2019 amounted to €13.
1 billion, down 1%
year-on-year.
Adjusted EBITDA amounted to €2,153 million, compared to €
2,150 million in 2018.
Sales in the Resource Efficiency segment were €5.
69 billion, unchanged from 2018, and sales in the Nutrition & Consumer Chemicals segment were €4.
58 billion, down 1% year-on-year.
Sales in the Functional Materials segment amounted to €2.
04 billion, down 9 percent
year-on-year.
Evonik expects sales
growth in the Specialty Chemicals segment in 2020.
The company expects sales to remain stable in 2020, with adjusted EBITDA of 2 billion ~ 2.
3 billion euros
.


BP achieved a net profit of US$3.
515 billion in 2019, down 64.
8%
year-on-year.
Among them, in the fourth quarter of 2019, BP had a net loss of $4 million; Operating income was $71.
12 billion, down from $75.
68 billion
in the same period in 2018.
A total of $9.
4 billion in divestitures were completed in 2019, and the $
10 billion divestiture target will be achieved ahead of schedule by the end of 2020.
The company's gearing ratio declined further, to 31.
1%
from 31.
7% in the third quarter of 2019.


Covestro generated sales of €12.
4 billion in 2019, down 15.
1 percent year-on-year; EBITDA amounted to around €1.
6 billion, down 49.
9 percent
year-on-year.
Core sales are expected to achieve low-single-digit percentage growth in 2020, and EBITDA will be between 1 billion ~ 1.
5 billion euros, of which EBITDA in the first quarter of 2020 is expected to be between 200 million ~ 280 million euros
.